🇺🇸 FDA
Patent

US 10501482

Compounds for treating spinal muscular atrophy

granted A61PA61P21/00A61P21/04

Quick answer

US patent 10501482 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P21/00, A61P21/04, A61P25/00, A61P25/02